Table 1.
Baseline characteristics of study participants who entered into the 6-month study by group and gendera
| HPD |
SPD |
|||||
|---|---|---|---|---|---|---|
| all (n = 59) | males (n = 26) | females (n = 33) | all (= 59) | males (n = 18) | females (n = 41) | |
| Age, years | 47.4 ± 11.5 | 44.8 ± 10.0 | 48.4 ± 12.1 | 41.1 ± 10.6 | 42.0 ± 9.8 | 40.4 ± 11.3 |
| Height, cm | 161.0 ± 8.6 | 169.0 ± 8.5 | 157.8 ± 6.3 | 164.0 ± 8.4 | 169.2 ± 8.5 | 159.9 ± 5.8 |
| Weight, kg | 85.4 ± 22.4 | 93.9 ± 25.1 | 82.0 ± 20.6 | 92.4 ± 19.2 | 99.2 ± 21.0 | 87.1 ± 16.1 |
| BMI, kg/m2 | 31.5 ± 4.7 | 31.5 ± 5.0 | 31.5 ± 4.6 | 33.3 ± 5.0 | 33.9 ± 5.9 | 32.8 ± 4.3 |
| Waist circumference, cm | 102.9 ± 14.5 | 107.8 ± 14.7 | 101.0 ± 14.1 | 107.6 ± 14.4 | 113.0 ± 16.0 | 103.7 ± 11.8 |
| Systolic blood pressure, mm Hg | 128.3 ± 16.8 | 130.0 ± 14.3 | 127.3 ± 18.7 | 129.6 ± 17.0 | 131.8 ± 10.6 | 128.7 ± 18.9 |
| Diastolic blood pressure, mm Hg | 82.1 ± 9.5 | 82.3 ± 8.9 | 81.8 ± 10.0 | 78.1 ± 8.6 | 82.6 ± 7.0 | 76.3 ± 8.6 |
| Fasting blood glucose, mg/dl | 82.4 ± 14.6 | 83.2 ± 10.9 | 81.8 ± 17.1 | 86.2 ± 17.1 | 92.6 ± 21.2 | 83.7 ± 14.7 |
| Insulin, μU/ml | 13.8 ± 6.7 | 14.6 ± 6.7 | 13.2 ± 6.7 | 14.5 ± 7.1 | 15.7 ± 7.7 | 14.1 ± 6.9 |
| Triglycerides, mg/dl | 186.2 ± 101.3 | 205 ± 118.4 | 172.4 ± 86.2 | 201.7 ± 88.3 | 233.5 ± 106.5 | 189.9 ± 78.6 |
| Total cholesterol, mg/dl | 174.4 ± 43.3 | 173.9 ± 45.3 | 174.9 ± 42.5 | 175.9 ± 40.9 | 177 ± 40.2 | 175.5 ± 41.6 |
| HDL cholesterol, mg/dl | 35.8 ± 9 | 33.7 ± 7.2 | 37.3 ± 10.0 | 36.5 ± 9.0 | 34.5 ± 9.2 | 37.2 ± 9.0 |
a
For all baseline characteristics there were no statistically significant between-group differences (Kruskal-Wallis test).